Changeflow GovPing Pharma & Drug Safety USPTO Patent Application for Photoprotective Sy...
Routine Notice Added Final

USPTO Patent Application for Photoprotective System

Favicon for changeflow.com ChangeBridge: Patent Apps - Pharma (A61K)
Published November 24th, 2025
Detected March 26th, 2026
Email

Summary

The USPTO has published a patent application (US20260083654A1) for a photoprotective system consisting of four specific sunscreens, assigned to PIERRE FABRE DERMO-COSMETIQUE. The application details a cosmetic or pharmaceutical composition with a photoprotective system representing 4% to 20% by weight.

What changed

The United States Patent and Trademark Office (USPTO) has published patent application US20260083654A1, filed on November 24, 2025, by PIERRE FABRE DERMO-COSMETIQUE. The application describes a photoprotective system comprising four specific chemical compounds: 5,6,5′,6′-tetraphenyl-3,3′-(1,4-phenylene)-bis[1,2,4]triazine, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine, hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, and a solar filter from a specified group. This system is intended for use in cosmetic or pharmaceutical compositions, where it constitutes between 4% and 20% of the total weight.

This publication represents a new patent application and does not impose immediate compliance obligations on regulated entities. However, it signifies potential future intellectual property protection for PIERRE FABRE DERMO-COSMETIQUE concerning this photoprotective system. Companies operating in the pharmaceutical and cosmetic sectors should be aware of this filing as it may impact future product development and market exclusivity in the area of sun protection formulations.

Source document (simplified)

← USPTO Patent Applications

PHOTOPROTECTIVE SYSTEM CONSISTING OF 4 SUNSCREENS

Application US20260083654A1 Kind: A1 Mar 26, 2026

Assignee

PIERRE FABRE DERMO-COSMETIQUE

Inventors

Roxane PROVOST, Stéphanie PAULET, Hélène DROMIGNY, Valérie PERIER

Abstract

The present invention relates to a cosmetic or pharmaceutical composition comprising at least one cosmetically or pharmaceutically acceptable excipient and a photoprotective system consisting of: (a) 5,6,5′,6′-tetraphenyl-3,3′-(1,4-phenylene)-bis[1,2,4]triazine, (b) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine, (c) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, and (d) a solar filter selected from the group comprised of ethylhexyl triazone, diethylhexyl butamido triazone and 2-ethylhexyl salicylate, wherein the photoprotective system represents between 4% and 20% by weight of the composition relative to the total weight of the composition.

CPC Classifications

A61K 8/4966 A61K 8/06 A61K 8/37 A61K 8/411 A61Q 17/04 A61K 2800/30 A61K 2800/412 A61K 2800/5922

Filing Date

2025-11-24

Application No.

19398527

View original document →

Named provisions

Assignee Inventors Abstract CPC Classifications Filing Date Application No.

Classification

Agency
USPTO
Published
November 24th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083654A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Labeling Product Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Cosmetics Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.